These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28910257)

  • 1. Between a rock and a hard place: Prescription opioid restrictions in the time of fentanyl and other street drug adulterants.
    Cheng T; DeBeck K
    Can J Public Health; 2017 Sep; 108(3):e325-e327. PubMed ID: 28910257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Emerging Role of Toxic Adulterants in Street Drugs in the US Illicit Opioid Crisis.
    Singh VM; Browne T; Montgomery J
    Public Health Rep; 2020 Jan; 135(1):6-10. PubMed ID: 31738861
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review.
    Fischer B; Argento E
    Pain Physician; 2012 Jul; 15(3 Suppl):ES191-203. PubMed ID: 22786457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study.
    Smolina K; Crabtree A; Chong M; Park M; Mill C; Zhao B; Schütz CG
    Subst Abus; 2022; 43(1):92-98. PubMed ID: 32441588
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK; Tupper KW; Fairbairn N
    Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing the benefits and reducing the harms of prescription opioid analgesics.
    Hallinan R; Osborn M; Cohen M; Dobbin M; Wodak A
    Drug Alcohol Rev; 2011 May; 30(3):315-23. PubMed ID: 21545563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic.
    Manchikanti L; Sanapati J; Benyamin RM; Atluri S; Kaye AD; Hirsch JA
    Pain Physician; 2018 Jul; 21(4):309-326. PubMed ID: 30045589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis.
    Dassieu L; Kaboré JL; Choinière M; Arruda N; Roy É
    Int J Drug Policy; 2019 Sep; 71():150-156. PubMed ID: 30975594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Today's fentanyl crisis: Prohibition's Iron Law, revisited.
    Beletsky L; Davis CS
    Int J Drug Policy; 2017 Aug; 46():156-159. PubMed ID: 28735773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How many people in Canada use prescription opioids non-medically in general and street drug using populations?
    Popova S; Patra J; Mohapatra S; Fischer B; Rehm J
    Can J Public Health; 2009; 100(2):104-8. PubMed ID: 19839284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National drug control policy and prescription drug abuse: facts and fallacies.
    Manchikanti L
    Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns and history of prescription drug use among opioid-related drug overdose cases in British Columbia, Canada, 2015-2016.
    Smolina K; Crabtree A; Chong M; Zhao B; Park M; Mill C; Schütz CG
    Drug Alcohol Depend; 2019 Jan; 194():151-158. PubMed ID: 30439611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Opioid Epidemic and the Role of the Occupational Health Nurse.
    Higgins SA; Simons J
    Workplace Health Saf; 2019 Jan; 67(1):36-45. PubMed ID: 30305006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing the harms of prescription opioids: a case for pharmacists.
    Sproule BA
    Drug Alcohol Rev; 2011 May; 30(3):327-9. PubMed ID: 21545565
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescription opioids, abuse and public health in Canada: is fentanyl the new centre of the opioid crisis?
    Fischer B; Russell C; Murphy Y; Kurdyak P
    Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1334-6. PubMed ID: 26502744
    [No Abstract]   [Full Text] [Related]  

  • 16. Association Between Socio-Demographic and Health Functioning Variables Among Patients with Opioid Use Disorder Introduced by Prescription: A Prospective Cohort Study.
    Sanger N; Bhatt M; Shams I; Shahid H; Luo C; Tam SL; Samaan MC; de Souza R; Thabane L; Samaan Z
    Pain Physician; 2018 Nov; 21(6):E623-E632. PubMed ID: 30508993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips.
    Lockwood TE; Vervoordt A; Lieberman M
    Harm Reduct J; 2021 Mar; 18(1):30. PubMed ID: 33750405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
    Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
    Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid prescription patterns in Germany and the global opioid epidemic: Systematic review of available evidence.
    Rosner B; Neicun J; Yang JC; Roman-Urrestarazu A
    PLoS One; 2019; 14(8):e0221153. PubMed ID: 31461466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A harm reductionist response.
    Brogan D; Kelsall J
    Drug Alcohol Rev; 2011 May; 30(3):330-1. PubMed ID: 21545566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.